Discontinued — last reported Q4 '24

Business Segments · Segment operating income

Life Science Member — Segment operating income

STERIS Life Science Member — Segment operating income increased by 8.3% to $58.13M in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 2.5%, from $56.74M to $58.13M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ2 2016
Last reportedQ4 2024
Rolls up toOperating Income

How to read this metric

Higher values indicate strong segment-level profitability and effective management of costs and revenues.

Detailed definition

This metric represents the final operating income for the Life Science segment after accounting for all relevant segment...

Peer comparison

Standard segment operating income metric used across all public companies to report divisional performance.

Metric ID: ste_segment_life_science_member_segment_operating_income

Historical Data

12 periods
 Q2 '21Q3 '21Q4 '21Q2 '22Q3 '22Q4 '22Q2 '23Q3 '23Q4 '23Q2 '24Q3 '24Q4 '24
Value$49.09M$57.52M$52.03M$55.31M$48.62M$45.25M$49.84M$50.28M$56.74M$52.58M$53.70M$58.13M
QoQ Change+17.2%-9.5%+6.3%-12.1%-6.9%+10.1%+0.9%+12.8%-7.3%+2.1%+8.3%
YoY Change+12.7%-15.5%-13.0%-9.9%+3.4%+25.4%+5.5%+6.8%+2.5%
Range$45.25M$58.13M
CAGR+6.3%
Avg YoY Growth+2.0%
Median YoY Growth+3.4%
Current Streak2 quarters growth

Frequently Asked Questions

What is STERIS's life science member — segment operating income?
STERIS (STE) reported life science member — segment operating income of $58.13M in Q4 2024.
How has STERIS's life science member — segment operating income changed year-over-year?
STERIS's life science member — segment operating income increased by 2.5% year-over-year, from $56.74M to $58.13M.
What does life science member — segment operating income mean?
The final operating profit of the Life Science segment after all adjustments.